Intec Pharma Ltd. (NTEC)’s Financial Results Comparing With Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI)

Intec Pharma Ltd. (NASDAQ:NTEC) and Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI), both competing one another are Biotechnology companies. We will contrast their analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation.

Valuation and Earnings

Table 1 shows the gross revenue, earnings per share and valuation for Intec Pharma Ltd. and Spectrum Pharmaceuticals Inc.

Profitability

Table 2 has Intec Pharma Ltd. and Spectrum Pharmaceuticals Inc.’s net margins, return on equity and return on assets.

Analyst Recommendations

Ratings and Recommendations for Intec Pharma Ltd. and Spectrum Pharmaceuticals Inc. can be find in next table.

Competitively Spectrum Pharmaceuticals Inc. has an average target price of $24, with potential upside of 116.80%.

Insider Institutional Ownership

The shares of both Intec Pharma Ltd. and Spectrum Pharmaceuticals Inc. are owned by institutional investors at 40.62% and 84% respectively. 11.4% are Intec Pharma Ltd.’s share

... read more at: https://dminute.com/2019/02/11/intec-pharma-ltd-ntecs-financial-results-comparing-with-spectrum-pharmaceuticals-inc-nasdaqsppi/

by